Blog
RSS FeedPosted by Michael Wonder on 12 Jun 2020
NICE rejects Sanofi's Cablivi in draft guidelines
12 June 2020 - NICE has drawn up draft guidelines rejecting Sanofi's Cablivi (caplacizumab) for use alongside plasma exchange and immunosuppression ...
Posted by Michael Wonder on 11 Jun 2020
Tafamidis for treating transthyretin amyloid cardiomyopathy
11 June 2020 - The Department of Health and Social Care has asked the NICE to produce guidance on using tafamidis ...
Posted by Michael Wonder on 10 Jun 2020
Final NHS green light for Roche's Kadcyla
10 June 2020 - NICE has published final guidance backing NHS use of Roche's Kadcyla (trastuzumab emtansine) for the adjuvant ...
Posted by Michael Wonder on 09 Jun 2020
UK post-Brexit drug stockpiles at risk amid virus
8 June 2020 - The UK has been warned by the pharmaceutical industry that some stockpiles of medical supplies have ...
Posted by Michael Wonder on 08 Jun 2020
NICE publishes appraisal consultation for isatuximab in combination with pomalidomide and dexamethasone for treating patients with relapsed and refractory multiple myeloma
4 June 2020 - The appraisal committee has considered the evidence submitted by the company and the views of non-company consultees ...
Posted by Michael Wonder on 04 Jun 2020
NICE publishes final guidance backing Teva's Ajovy for migraine
4 June 2020 - NICE has now published final guidelines endorsing the NHS use of Teva’s Ajovy (fremanezumab) to prevent ...
Posted by Michael Wonder on 03 Jun 2020
How a US-UK trade agreement could affect NHS drug prices
1 June 2020 - The governments of the UK and US are working on the outlines of a trade agreement. ...
Posted by Michael Wonder on 27 May 2020
NICE issues final guidance on NHS use of Bayer's Vitrakvi
27 May 2020 - The NICE has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety ...
Posted by Michael Wonder on 27 May 2020
NICE recommends treatment for type of small-cell lung cancer
27 May 2020 - A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE. ...
Posted by Michael Wonder on 26 May 2020
NICE Chairman Sharmila Nebhrajani begins her new role
26 May 2020 - NICE is delighted to announce that today Sharmila Nebhrajani, OBE, has taken up her position as its ...
Posted by Michael Wonder on 22 May 2020
Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE
22 May 2020 - Draft guidance published today by NICE recommends atezolizumab for treating people with a type of breast cancer, ...
Posted by Michael Wonder on 19 May 2020
UK bulk buys hydroxychloroquine as potential COVID-19 treatment
20 May 2020 - Hydroxychloroquine is being bought in bulk by the UK in case it does turn out to ...
Posted by Michael Wonder on 13 May 2020
NICE backs drug for lymphoma from Roche
13 May 2020 - NICE has recommended NHS funding for a cancer drug, giving final guidance on a new option ...
Posted by Michael Wonder on 13 May 2020
NICE final guidance backs Pfizer's Lorviqua
13 May 2020 - NICE has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of ...
Posted by Michael Wonder on 07 May 2020
NICE draft guidance recommends new treatment option for people with early breast cancer
7 May 2020 - NICE has today published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) ...